SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
How to use FDA drug approval documents for evidence syntheses
9 references·2 citing·39 second hop
How to use FDA drug approval documents for evidence syntheses (2018)How to use FDA drug approval documents fo…Cochrane Handbook for Systematic Reviews of Interventions (2020)Cochrane Handbook for Systema…Most systematic reviews of adverse effects did not include unpublished data (2016)Most systematic reviews of ad…Strategies for obtaining unpublished drug trial data: a qualitative interview study (2013)Strategies for obtaining unpu…Searching for unpublished data for Cochrane reviews: cross sectional study (2013)Searching for unpublished dat…Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses (2012)Effect of reporting bias on m…Cochrane Handbook for Systematic Reviews of Interventions (2008)Cochrane Handbook for Systema…Practical methods for incorporating summary time-to-event data into meta-analysis (2007)Practical methods for incorpo…How useful are unpublished data from the Food and Drug Administration in meta-analysis? (2003)How useful are unpublished da…Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints (1998)Extracting summary statistics…Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016 (2020)Clinical Trial Evidence Suppo…The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs (2018)The Comparative Effectiveness…Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials (2004)Full publication of results initially presented in abstracts (2007)Search for unpublished data by systematic reviewers: an audit (2017)Challenges of identifying unpublished data from clinical trials: Getting the best out of clinical trials registers and other novel sources (2018)Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (2008)The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews (2010)Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research (2017)COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time (2019)SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025)Meta-analysis in clinical trials (1986)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Coefficient Alpha and the Internal Structure of Tests (1951)HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT (2004)Finding evidence for comparing medical interventions: AHRQ and the Effective Health Care Program (2011)Handbook of Qualitative Research (1994)How Many Interviews Are Enough? (2005)Barriers to and facilitators of interventions to counter publication bias: thematic analysis of scholarly articles and stakeholder interviews (2014)Contacting of authors by systematic reviewers: protocol for a cross-sectional study and a survey (2017)Searching practices and inclusion of unpublished studies in systematic reviews of diagnostic accuracy (2020)Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies (2008)Finding What Works in Health Care: Standards for Systematic Reviews (2013)Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)The development of search filters for adverse effects of surgical interventions in medline and E mbase (2018)Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study (2024)Measuring inconsistency in meta-analyses (2003)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012)Positive psychology interventions: a meta-analysis of randomized controlled studies (2013)AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017)Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas (2021)
this work references cited by second hop

References

  • 2008Cochrane Handbook for Systematic Reviews of Interventions25,045 cited
  • 2007Practical methods for incorporating summary time-to-event data into meta-analysis6,205 cited
  • 2020Cochrane Handbook for Systematic Reviews of Interventions5,670 cited
  • 1998Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints4,809 cited
  • 2012Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses254 cited
  • 2003How useful are unpublished data from the Food and Drug Administration in meta-analysis?52 cited
  • 2013Searching for unpublished data for Cochrane reviews: cross sectional study43 cited
  • 2016Most systematic reviews of adverse effects did not include unpublished data30 cited
  • 2013Strategies for obtaining unpublished drug trial data: a qualitative interview study30 cited

Cited by

  • 2020Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 201697 cited
  • 2018The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs20 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work